Opinion
Video
Author(s):
Looking to the future treatment landscape in prostate cancer, the panel provides closing thoughts on the trajectory of the utilization of PSMA-PET imaging and the unmet needs it might address.
FDA reports Urgent Field Safety Notice on mini PCNL sheath
Dr. Murphy on increasing diversity in cancer clinical trials
Agreement reached for public reimbursement of Pluvicto in Canada
Dr. Schwen on focal therapies for prostate cancer
Adding CAN-2409 to radiation improves DFS in localized prostate cancer
Published data show noninferior treatment-free survival with HIFU vs RP